This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has ...

The innovative product is called the Resorbable Fibrillated Scaffold (RFS). In a clinical study, doctors implanted this ...

STENTiT implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the ...

The characteristics of combat trauma to blood vessels include deep and widespread damage to the vascular wall, often ...

One such innovation is the Bioresorbable Scaffold (BRS)-a temporary stent designed to restore blood flow and then dissolve, leaving the artery free of any permanent implant. “Metal stents saved lives, ...

Diabetes mellitus is highly prevalent in patients with coronary atherosclerosis. As a result of several factors, including a ...

The CGuard Prime carotid stent. [Image from InspireMD] InspireMD announced that the FDA granted premarket approval (PMA) for its CGuard Prime carotid stent system. The CGuard embo ...

InspireMD shares soared after the company said federal regulators have granted premarket application approval for its CGuard Prime Carotid Stent System. The stock was up 50% at $3.72 in after-market ...

InspireMD, Inc. announced that the FDA has granted premarket approval (PMA) of the company’s CGuard Prime carotid stent syst ...